SHANGHAI, China, June 19 /Xinhua-PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced that it has posted its 2007 annual report on the Investor Relations page of its website at http://www.wuxipharmatech.com .
(Logo: http://www.prnasia.com/xprn/sa/200708281726.jpg )
The 2007 annual report includes a copy of the Company’s Form 20-F for the fiscal year ended December 31, 2007, which was filed with the U.S. Securities and Exchange Commission on June 16, 2008.
Shareholders can receive a hard copy of the annual report free of charge by sending a request through our website or by contacting our IR representatives stated below.
About WuXi PharmaTech
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech’s services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. For more information, please visit: http://www.wuxipharmatech.com .
For more information, please contact:
Investor Contact:
Dr. Hai Mi, Vice President
Corporate Communications
WuXi PharmaTech (Cayman) Inc.
Tel: +86-21-5046-3726
Email: ir@pharmatechs.com
Web: http://www.wuxipharmatech.com
Investor Relations (US):
Mahmoud Siddig, Director
Taylor Rafferty
Tel: +1-212-889-4350
Email: pharmatechs@taylor-rafferty.com
Web: http://www.taylor-rafferty.com
Investor Relations (HK):
Ruby Yim, Managing Director
Taylor Rafferty
Tel: +852-3196-3712
Email: pharmatechs@taylor-rafferty.com
Web: http://www.taylor-rafferty.com
Media Contact:
John Dudzinsky, Director
Taylor Rafferty
Tel: +1-212-889-4350
Email: pharmatechs@taylor-rafferty.com
Web: http://www.taylor-rafferty.com
